WARNING: Since June 12, 2023, HHC has been banned in France.
In recent months, HHC (hexahydrocannabinol), a chemical derivative of cannabis, has sparked considerable debate and concern in France. Under pressure from addiction specialists and due to road safety concerns, it is slated to be added to the list of narcotics and therefore soon banned in the country.
What is HHC?
HHC is a synthetic compound derived from cannabis, developed in the 1940s by a researcher from the United States. Unlike THC and CBD found in cannabis plants, this derivative is entirely chemical. Nevertheless, it exhibits psychotropic effects similar to those of cannabis.
A regulatory loophole
Until now, HHC has benefited from a regulatory loophole that allowed it to be legally sold and consumed in France. It was not considered a narcotic and thus escaped drug laws. However, faced with growing concerns, the French Minister of Health has announced his intention to add HHC to the list of narcotics, ending its unrestricted sale.
The risks associated with HHC consumption
Several reasons are driving the French authorities to want to ban HHC, including:
- The psychotropic effects are similar to cannabis
- The lack of studies and perspective on the long-term effects of this substance
- The risks to road safety linked to the consumption of psychoactive substances
Furthermore, many HHC users are former cannabis users, which reinforces the idea that it is indeed a substitute drug.
Division within the CBD sector
The arrival of HHC in France has divided professionals in the CBD (cannabidiol) sector, another legal cannabis derivative with non-psychoactive effects. Some retailers have chosen to sell HHC in their shops, taking advantage of its temporary legality, while others categorically refuse to do so.
The search for recognition
This division is also explained by the desire of CBD professionals to gain recognition from the authorities. Indeed, the sector is still young and rapidly growing, and its players are seeking to distance themselves from the negative image often associated with cannabis. The prohibition of HHC could thus help clarify the situation and strengthen the legitimacy of CBD as a distinct and safe product.
An uncertain future for HHC in Europe
As France prepares to ban cannabis (HHC), other European countries have already taken this step. The cannabis derivative is illegal in several European Union member states. However, the situation could change in the future if in-depth studies reveal new information about the effects and risks associated with HHC use.
In conclusion, HHC is on the verge of being banned in France, joining the list of narcotics. This decision is motivated by concerns regarding public health and road safety, but also by the desire to clarify the situation regarding the different cannabis derivatives and their uses. Professionals in the CBD sector can thus hope for greater recognition from the authorities, while consumers will have to turn to other legal and less controversial alternatives.
Sources
- https://actu.fr/bretagne/rennes_35238/hhc-a-rennes-consommateurs-vendeur-et-addictologue-temoignent_59607101.html
- https://www.konbini.com/videos/cest-quoi-le-hhc-et-pourquoi-ca-va-bientot-etre-interdit/
- https://lecannabiste.com/pourquoi-le-hhc-na-rien-a-voir-avec-du-cannabis/
- https://www.santenews.eu/le-hhc-derive-du-cannabis-prochainement-interdit-dans-lhexagone/
Editor-in-Chief specializing in CBD
Julien, born on July 17, 1978, in the Paris region, is a prominent writer and expert in the field of CBD products. Following his studies, Julien developed a passion for natural remedies, including CBD. In 2022, he joined the CBD.fr team as an expert and regular contributor. Thanks to his scientific expertise and clear writing style, Julien helps demystify the complexities of CBD, while highlighting its benefits and potential applications through his articles and conference presentations.
